LifeCell   Report issue

For profit
Founded: Branchburg NJ United States (1986)
Status: Acquired by Allergan PLC (2015) (2016) → now AbbVie (2019)

Organization Overview

First Clinical Trial
1999
NCT00038012
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LifeCell

Active Ingredients

Drugs in Other Trials (3)

carboplatin (paraplatin) (1 trial)

platelets (1 trial)

thrombopoietin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3